MLB’s Rob Manfred attended a PED seminar yesterday and offered some more words about HGH testing in baseball:
Manfred said that the positive test in England “is an important
confirmation of the strength and science involved” in the H.G.H. blood
test and that baseball was working to apply the test on a widespread
An HGH test may or may not be workable and wonderful and all of that — I really don’t know enough about it, or the drug, to say — but I am rather surprised that everyone keeps referring to this rugby player as evidence that people need to get moving on the test.
Why? Because all of the stories that have come out since that test note that the player wasn’t caught merely by testing. Rather, his league had intelligence (i.e. a tip) that he was using HGH, and then went to specifically test him based on that tip. If they didn’t have the tip, they never would have caught the guy in all likelihood, because HGH doesn’t stay in the bloodstream that long. Indeed, the UK anti-doping agency that caught the guy is on record as saying that intelligence, as opposed to testing, is becoming far more important in their battle against HGH. The same sort of intelligence that nabbed Braves’ prospect Jordan Schafer for HGH just last year.
I don’t offer this to slam baseball’s desire to implement HGH testing. As with most things, a combination approach is best. Do some testing if it makes sense. Use intelligence too. It’s all good. It’s just probably worth remembering that there is more to life than just testing, and that, contrary to what so many writers say, the presence or absence of an HGH test doesn’t automatically render baseball’s drug program effective or ineffective.
Jon Heyman of FanRag Sports reports that Mets outfielder Yoenis Cespedes will opt out of his contract shortly after the World Series concludes. Cespedes, who earned $17.5 million for the 2016 season, has two years and $47.5 million remaining on his deal which includes an opt-out clause.
That Cespedes plans to opt out isn’t surprising as he’s almost certain to get a better contract entering a weak free agent market. He hit a terrific .280/.354/.530 with 31 home runs and 86 RBI in 543 plate appearances for the Mets this past season.
It remains to be seen how the Mets will deal with potentially losing Cespedes. They can pick up a $13 million club option for Jay Bruce, but he performed terribly after joining the Mets in a trade from the Reds. The Mets could also go after free agents Jose Bautista or Mark Trumbo. Curtis Granderson and Michael Conforto will handle the other two outfield positions.
Major League Baseball announced on Wednesday that former Red Sox DH David Ortiz and Cubs third baseman Kris Bryant won the 2016 Hank Aaron Award in their respective leagues.
Ortiz, 40, flourished in his final season, batting .315/.401/.620 with 38 home runs and 127 RBI in 626 plate appearances during the regular season. His .620 slugging percentage, 1.021 OPS, and 48 doubles led the majors while his 127 RBI led the American League. Ortiz also won the Hank Aaron Award back in 2005.
Bryant, 24, is the likely winner of the National League Most Valuable Player Award as well. He hit .292/.385/.554 with 39 home runs and 102 RBI over 699 plate appearances. He also led the league by scoring 121 runs. Bryant is the first Cub to win the Hank Aaron Award since Aramis Ramirez in 2008.
Last year’s winners in the AL and NL, respectively, were Josh Donaldson and Bryce Harper.